Spectrometers

908 Devices to Report Second Quarter Financial Results on August 4, 2021

Retrieved on: 
Wednesday, July 21, 2021
Branches of biology, Chemical pathology, Clinical pathology, Mass spectrometry, Spectrometers, Handheld game console, Science and technology, Science

BOSTON, July 21, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS)a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2021 before market open on Wednesday, August 4, 2021.

Key Points: 
  • BOSTON, July 21, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS)a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2021 before market open on Wednesday, August 4, 2021.
  • Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
  • Live audio of the webcast will be available on the Investors section of the company website at: www.908devices.com .
  • 908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.

Clinical Mass Spectrometry Market to reach USD 1.83 billion growth|COVID-19 Impact and Analysis|Technavio

Retrieved on: 
Friday, July 16, 2021
Occupational safety and health, Articles, Health, Medical specialties, Chemical pathology, Mass spectrometry, Spectrometers, COVID-19 pandemic, COVID-19

The report offers a detailed analysis of the impact of the COVID-19 pandemic on the clinical mass spectrometry market in optimistic, probable, and pessimistic forecast scenarios.

Key Points: 
  • The report offers a detailed analysis of the impact of the COVID-19 pandemic on the clinical mass spectrometry market in optimistic, probable, and pessimistic forecast scenarios.
  • COVID-19 Impact Analysis on Clinical Mass Spectrometry Market can now be gained through our report.
  • The clinical mass spectrometry market will witness a Neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic.
  • Get report snapshot here to get a detailed market share analysis of market participants during COVID-19 lockdown:
    Clinical Mass Spectrometry Market 2021-2025: Segmentation
    The clinical mass spectrometry market is segmented as below:

Trace Matters Successfully Demonstrates Proof-of-Principle for SPion™ Technology in Collaboration With Thermo Fisher Scientific

Retrieved on: 
Tuesday, June 8, 2021
Environment, Technology, Medical devices, Engineering, Aerospace, Manufacturing, Hardware, Health, Science, Other Science, Instrumental analysis, Chemistry, Physical sciences, Chemical pathology, Clinical pathology, Mass spectrometry, Spectrometers, Albert J. R. Heck

Trace Matters Scientific in collaboration with Thermo Fisher Scientific successfully demonstrated the proof-of-principle for SPionTM Technology for mass spectrometry.

Key Points: 
  • Trace Matters Scientific in collaboration with Thermo Fisher Scientific successfully demonstrated the proof-of-principle for SPionTM Technology for mass spectrometry.
  • This collaboration also allowed Trace Matters to successfully construct and test the interface for Thermo Fishers mass spectrometers, which are widely used in many applications.
  • Trace Matters is a technology startup focused on developing the next generation of mass spectrometry technologies for a variety of demanding applications.
  • Trace Matters technologies include innovative mass spectrometry hardware, methods, and applications to solve the most demanding mass spectrometry analysis needs in various industries.

Innovative Mass Spectrometer Designed for Small Molecule Analysis

Retrieved on: 
Monday, June 7, 2021
Mass spectrometry, Science, Natural sciences, Chemical pathology, Spectrometers, Orbitrap, Thermo Fisher Scientific

SAN JOSE, Calif., June 7, 2021 /PRNewswire/ --Small molecule researchers in academia, pharmaceutical, and biopharmaceutical industries can now use a new, intelligent mass spectrometer (MS) to reveal complex chemical structures with confidence, ease and experimental versatility.

Key Points: 
  • SAN JOSE, Calif., June 7, 2021 /PRNewswire/ --Small molecule researchers in academia, pharmaceutical, and biopharmaceutical industries can now use a new, intelligent mass spectrometer (MS) to reveal complex chemical structures with confidence, ease and experimental versatility.
  • The Thermo Scientific Orbitrap IQ-X Tribrid mass spectrometer has been designed specifically for small-molecule structural elucidation of metabolites and unknown compounds.
  • The MS system provides a fit-for-purpose, new AcquireX workflow enabled by the trusted Thermo Scientific Tribrid architecture to acquire high-quality data.
  • To find out more about the Thermo Scientific Orbitrap IQ-X Tribrid mass spectrometer, please visit www.thermofisher.com/OrbitrapIQ-X .

IonSense Appoints Jeff Zonderman as CEO as it Expands Its Direct Analysis Mass Spectrometry Technology to New Platforms

Retrieved on: 
Thursday, June 3, 2021
Other Defense, Oil, Gas, Chemicals, Plastics, Contracts, Security, Energy, Manufacturing, Technology, Nanotechnology, Defense, Environment, Science, Other Science, Packaging, Research, Engineering, Programming languages, Computer programming, Software engineering, Measuring instruments, Laboratory equipment, Chemical pathology, Mass spectrometry, Spectrometers, IonSense, Dart, Standard Performance Evaluation Corporation

The appointment is key to the companys strategy for accelerated growth in applied markets including forensic and security applications.

Key Points: 
  • The appointment is key to the companys strategy for accelerated growth in applied markets including forensic and security applications.
  • Mass Spec is finally catching up with IonSenses DART, comments Jeff Zonderman.
  • Increased performance at a lower cost expands the realm of whats historically been possible by mass spec instrumentation.
  • It is a privilege to have the opportunity to join the IonSense team at such an exciting time.

Ball Aerospace Ships Pollution Monitoring Instrument to Spacecraft Manufacturer for Integration

Retrieved on: 
Friday, May 21, 2021
Spacecraft, Spectrometers, Spaceflight, Satellite meteorology, In spaceflight, National Oceanic and Atmospheric Administration, Tropospheric Emissions: Monitoring of Pollution, Ball Aerospace & Technologies, Earth observation satellite

b'BROOMFIELD, Colo., May 21, 2021 /PRNewswire/ --Ball Aerospace shipped NASA\'s Tropospheric Emission: Monitoring of Pollution (TEMPO) spectrometer, an air quality monitoring instrument, to the spacecraft manufacturer for integration.\nBall will continue to work closely with NASA and the manufacturer to support spacecraft integration and testing.

Key Points: 
  • b'BROOMFIELD, Colo., May 21, 2021 /PRNewswire/ --Ball Aerospace shipped NASA\'s Tropospheric Emission: Monitoring of Pollution (TEMPO) spectrometer, an air quality monitoring instrument, to the spacecraft manufacturer for integration.\nBall will continue to work closely with NASA and the manufacturer to support spacecraft integration and testing.
  • "This rapid tempo of measurements will advance our understanding pollution in the atmosphere from Mexico City to Canada and from coast to coast.
  • Ball completed the TEMPO instrument in 2018, delivered it to NASA Langley Research Center after a successful final acceptance review and stored and maintained the instrument until the spacecraft was ready for integration.\nLeveraging 40 years of heritage in Earth-observing instruments, Ball built the TEMPO instrument in tandem with the Geostationary Environmental Monitoring Spectrometer (GEMS), the Asian element of a global air quality monitoring constellation of geostationary satellites.
  • Ball is currently involved in several other space-based environmental science and monitoring missions.

908 Devices Launches New Aerosol Module for Handheld MX908

Retrieved on: 
Tuesday, May 11, 2021
Chemicals, Plastics, Health, Technology, Other Technology, Manufacturing, Pharmaceutical, Technology, Computing, Science and technology, Mobile computers, Information appliances, Spectrometers, Measuring instruments, Android, Smartphones, Mass spectrometry, Mobile device, Personal digital assistant

b'908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced updates to its MX908 handheld mass spec device including a first-of-its-kind aerosol module to detect and identify aerosolized chemical threats; added targets allowing responders to recognize additional priority drug substances; and activation of a Bluetooth capability to export reports and device history to Android devices.

Key Points: 
  • b'908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced updates to its MX908 handheld mass spec device including a first-of-its-kind aerosol module to detect and identify aerosolized chemical threats; added targets allowing responders to recognize additional priority drug substances; and activation of a Bluetooth capability to export reports and device history to Android devices.
  • \xe2\x80\x9cAerosolized threats have unique physical properties and behavior that make it difficult for legacy detectors to identify them.
  • By pairing with the Remote application on an Android device, MX908 now provides a more rapid and efficient workflow for sharing results and accessing technical support from 908 Devices.
  • These updates come on the heels of the company\xe2\x80\x99s announcement of a $25 million multi-year deal with U.S. Army .\nTo learn more about 908 Devices, please visit: https://908devices.com/ .\n908 Devices (NASDAQ:MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.

908 Devices and Bio-Techne Announce Joint Collaboration

Retrieved on: 
Tuesday, May 4, 2021
Science, Biotechnology, Research, Pharmaceutical, Health, Medical devices, Technology, Other Technology, Science and technology, Technology, Equipment, Chemical pathology, Clinical pathology, Mass spectrometry, Spectrometers, Mobile device, 908 Devices, Bio-Techne, 908 DEVICES, BIO-TECHNE

b'908 Devices (NASDAQ: MASS) and Bio-Techne Corporation (NASDAQ: TECH) today announced a joint collaboration to develop an extended workflow solution for protein characterization.

Key Points: 
  • b'908 Devices (NASDAQ: MASS) and Bio-Techne Corporation (NASDAQ: TECH) today announced a joint collaboration to develop an extended workflow solution for protein characterization.
  • \xe2\x80\x9cThis collaboration helps advance our reach into the biopharmaceutical market.\xe2\x80\x9d\n\xe2\x80\x9cWe are very excited to collaborate with 908 Devices to provide an integrated workflow that enables fraction analysis for our Maurice users.
  • \xe2\x80\x9cOur iCE technology has been the gold standard in protein charge characterization for more than 20 years and this collaboration will provide additional value to the iCE community.\xe2\x80\x9d\n908 Devices (NASDAQ:MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.
  • For more information on Bio-Techne and its brands, please visit www.bio-techne.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210504005140/en/\n'

Worldwide Q-TOF Mass Spectrometry Industry to 2025 - Competitive Analysis and the Impact of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 9, 2021
Health, Technology, Other Technology, Other Science, Science, Pharmaceutical, Biotechnology, Mass spectrometry, Chemical pathology, Spectrometers, Science and technology, Science, Scientific method

The "Global Q-TOF Mass Spectrometry Market (2020-2025) by Application, Product Type, Sales Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Q-TOF Mass Spectrometry Market (2020-2025) by Application, Product Type, Sales Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Global Q-TOF Mass Spectrometry Market is estimated to be USD 872.4 Mn in 2020 and is expected to reach USD 1270.5 Mn by 2025, growing at a CAGR of 7.8%.
  • Also, many pharmaceuticals and biotechnological companies have increased the Research & Development activities in this field that helps in driving the growth of the market.
  • However, the high costs of Q-TOF instruments and the shortfall of professionals to make effective use of the technology may create hindrances in the growth of the Global Q-TOF Mass Spectrometry Market.

908 Devices Provides Handheld Mass Spec for Trace Detection to U.S. Border Patrol

Retrieved on: 
Thursday, April 8, 2021
Biotechnology, Technology, Health, Law enforcement, Emergency services, Pharmaceutical, Other Technology, Medical devices, Research, Public policy, Government, Science, Hardware, Science and technology, Technology, Information appliances, Mobile computers, Equipment, Clinical pathology, Mass spectrometry, Spectrometers, Mobile device, Handheld game console, United States Border Patrol, Spectrometry

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the U.S. Border Patrol selected the MX908 a handheld, battery-powered, mass spectrometry device to standardize its trace drug detection at 20 field locations across the U.S. borders, from North to South and in the Caribbean.

Key Points: 
  • 908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the U.S. Border Patrol selected the MX908 a handheld, battery-powered, mass spectrometry device to standardize its trace drug detection at 20 field locations across the U.S. borders, from North to South and in the Caribbean.
  • Were proud to support U.S. Border Patrol as they field our MX908 devices across their enterprise to provide their first responders with the ability to better serve and protect our borders and country, said John Kenneweg, Vice President of Government at 908 Devices.
  • Weve seen a rise in the creation and distribution of synthetic opioids in particular because not many technologies can identify drugs at these trace levels.
  • 908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.